City Pedia Web Search

Search results

1. Results From The WOW.Com Content Network

2. Sunglass Hut - Wikipedia

   en.wikipedia.org/wiki/Sunglass_Hut

   The first Sunglass Hut store opened in 1971 when optometrist Sanford L. Ziff set up in a freestanding kiosk in Miami's Dadeland Mall.The success of this kiosk prompted Ziff to open other Sunglass Hut locations in Miami, and by 1986, Ziff had opened approximately 100 Sunglass Hut outlets, achieving sales of $24 million a year.

3. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

4. Biden administration says Medicare negotiated price discounts ...

   www.aol.com/biden-administration-says-medicare...

   The list price of Merck's diabetes drug Januvia will be slashed to $113 for a 30-day supply from $527 as of 2023. Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer, will cost $231 for ...

5. Luxottica - Wikipedia

   en.wikipedia.org/wiki/Luxottica

   Luxottica. Luxottica Group S.p.A. is an Italian eyewear multinational corporation headquartered in Milan. As a vertically integrated company, Luxottica designs, manufactures, distributes, and retails its eyewear brands through its own subsidiaries. It is the largest eyewear company in the world. [5][6] It is, since October 2018, a subsidiary of ...

6. A complete guide to the very best Labor Day sales on ... - AOL

   www.aol.com/lifestyle/the-very-best-labor-day...

   The Best Labor Day Sales this year includes great deals such as a $65 mattress, a $20 set of sheets and 20% off Amazon bestselling pillows. Browse all of the deals available this Labor Day.

7. US FDA approves IntraBio's drug for rare genetic disease - AOL

   www.aol.com/news/us-fda-approves-intrabios-drug...

   On Sept. 20, the FDA approved Zevra's drug, Miplyffa, for the treatment of NPC - the first treatment to get a nod for the condition ... The approval was based on a late-stage clinical trial in 60 ...